|
When I last saw my onc, he gave me the article by Dr Gnant on the zoledronic acid. I did ask about the fact that the subjects were premenopausal and not her2. He said they were ovarian suppressed and similar to postmenopausal patients in that respect. He also believed the results would be the same for her2 patients.
I guess this is one of those times when definitive results may be a long way off. As long as the side effects aren't worse than the benefits I'm going to give it a try
__________________
Henny
Dx 3/07 IDC and DCIS Her2+ ER- PR-
Stage IIb 1/15 nodes
A/C, Taxol, Herceptin
Bilateral mastectomies with recon
Zometa 2/yr for 3 yrs- finished 8/2011
|
Threaded Mode